Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oded Shamriz

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|September 1, 2023
Administration of BNT162b2 mRNA COVID-19 vaccine to subjects with various allergic backgroundsYaarit Ribak, Limor Rubin, Aviv Talmon, et al.
Clinical Immunology (Orlando, Fla.)|March 4, 2014
Hematopoietic stem cell transplantation conditioning with use of rituximab in EBV related lymphoproliferative disordersOded Shamriz, Shoshana Revel Vilk, Dana G Wolf, et al.
Journal of Pediatric Hematology/Oncology|August 15, 2015
Bosentan-induced Reduction in Cyclosporine-A Levels: A Rare Interaction in an Infant With Osteopetrosis and Severe Pulmonary HyperetensionReem Masarwa, Oded Shamriz, Amir Zilkha, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 10, 2020
Allergic-like disorders and asthma in patients with common variable immunodeficiency: a multi-center experienceLimor Rubin, Oded Shamriz, Ori Toker, et al.
Clinical Immunology (Orlando, Fla.)|January 16, 2016
Deep intronic mis-splicing mutation in JAK3 gene underlies T-B+NK- severe combined immunodeficiency phenotypePolina Stepensky, Baerbel Keller, Oded Shamriz, et al.
European Journal of Pediatrics|May 20, 2018
Respiratory manifestations in LPS-responsive beige-like anchor (LRBA) protein-deficient patientsOded Shamriz, Bella Shadur, Adeeb NaserEddin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2023
Successful ligelizumab treatment of severe refractory solar urticariaYoav Hershkovitz, Israel Khanimov, Limor Rubin, et al.
BMC Immunology|April 8, 2025
Dual biological treatments in immune-mediated disorders: a single center experienceOded Shamriz, Elchanan Parnasa, Limor Rubin, et al.
Frontiers in Immunology|May 15, 2023
Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndromeLimor Rubin, Aviv Talmon, Yaarit Ribak, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Dupilumab for cancer-associated refractory pruritusAviv Talmon, Shlomo Elias, Limor Rubin, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|September 1, 2023
Administration of BNT162b2 mRNA COVID-19 vaccine to subjects with various allergic backgroundsYaarit Ribak, Limor Rubin, Aviv Talmon, et al.
Clinical Immunology (Orlando, Fla.)|March 4, 2014
Hematopoietic stem cell transplantation conditioning with use of rituximab in EBV related lymphoproliferative disordersOded Shamriz, Shoshana Revel Vilk, Dana G Wolf, et al.
Journal of Pediatric Hematology/Oncology|August 15, 2015
Bosentan-induced Reduction in Cyclosporine-A Levels: A Rare Interaction in an Infant With Osteopetrosis and Severe Pulmonary HyperetensionReem Masarwa, Oded Shamriz, Amir Zilkha, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 10, 2020
Allergic-like disorders and asthma in patients with common variable immunodeficiency: a multi-center experienceLimor Rubin, Oded Shamriz, Ori Toker, et al.
Clinical Immunology (Orlando, Fla.)|January 16, 2016
Deep intronic mis-splicing mutation in JAK3 gene underlies T-B+NK- severe combined immunodeficiency phenotypePolina Stepensky, Baerbel Keller, Oded Shamriz, et al.
European Journal of Pediatrics|May 20, 2018
Respiratory manifestations in LPS-responsive beige-like anchor (LRBA) protein-deficient patientsOded Shamriz, Bella Shadur, Adeeb NaserEddin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2023
Successful ligelizumab treatment of severe refractory solar urticariaYoav Hershkovitz, Israel Khanimov, Limor Rubin, et al.
BMC Immunology|April 8, 2025
Dual biological treatments in immune-mediated disorders: a single center experienceOded Shamriz, Elchanan Parnasa, Limor Rubin, et al.
Frontiers in Immunology|May 15, 2023
Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndromeLimor Rubin, Aviv Talmon, Yaarit Ribak, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Dupilumab for cancer-associated refractory pruritusAviv Talmon, Shlomo Elias, Limor Rubin, et al.
Pageof 8